(marketscreener.com) Consolidated revenues for the third quarter of 2019: €1.3 million, down 41% Sales of the Amazonia SIR stent temporarily suspended Consolidated cash position at September 30, 2019: €8.0...http://www.marketscreener.com/news/STENTYS-Financial-Information-for-the-Third-Quarter-of-2019--29366701/?utm_medium=RSS&utm_content=20191011
